Navigation Links
New Non-Drowsy CLARITIN(R) 12-Hour Gets Allergy Sufferers Through Their Busy Day
Date:9/1/2009

KENILWORTH, N.J., Sept. 1 /PRNewswire-FirstCall/ -- Schering-Plough Corporation (NYSE: SGP) today announced the introduction of CLARITIN 12-Hour, the only 12-hour allergy medicine found in the allergy aisle. New CLARITIN 12-Hour lasts all day and provides effective, non-drowsy relief from the worst indoor and outdoor allergy symptoms. The product is available for adults and children ages six and up.

(Photo: http://www.newscom.com/cgi-bin/prnh/20090901/NY68186)

"New CLARITIN 12-Hour offers the proven allergy relief people have relied on for years, with the added flexibility for people who want more control of their treatment," said Dr. John O'Mullane, group vice president, research and development, Schering-Plough Consumer Health Care. "Allergy sufferers can choose to treat their allergy symptoms for 12 or 24 hours depending on their individual needs."

Until now, sufferers shopping the allergy aisle had to choose between 4-6 hour products, which could cause drowsiness, or products offering 24 hours of relief. However, according to a recent study, 34% of allergy sufferers want something in between (1). Today, those sufferers finally have a non-drowsy option that meets their needs.

CLARITIN 12-Hour, which comes in convenient RediTabs(R) tablets, is great for people on the go since they dissolve quickly without water (2). It is also convenient for moms looking to give their kids all day allergy relief, while allowing the flexibility to re-dose at night, if needed.

Like other CLARITIN products, NEW CLARITIN 12-Hour is available without a prescription and treats allergy symptoms such as itchy, watery eyes, sneezing, and runny nose without drowsiness. CLARITIN 12-Hour can be found in most food, drug or mass retailers.

(1) 2007 Millward Brown Study

(2) Speed of dissolution does not imply speed of relief.

About CLARITIN

All CLARITIN(R) brand products are non-drowsy and available without a prescription. CLARITIN provides powerful allergy relief for 12 or 24 hours and comes in a variety of forms, including: CLARITIN Tablets, CLARITIN(R) Liqui-Gels(R), an easy-to-swallow liquid-filled capsule, and CLARITIN RediTabs tablets, a quickly dissolving tablet for ages 6 and older. And now, CLARITIN 12-Hour RediTabs provide the flexibility to manage allergy symptoms all day or all night.

CLARITIN-D(R) is available behind-the-counter in 12- or 24-hour extended release tablets and also includes the decongestant pseudoephedrine for powerful nasal congestion relief. CHILDREN'S CLARITIN(R) comes in great-tasting Grape Chewables or Syrup forms and is safe and effective for kids 2 and older.

Finally, CLARITIN Eye is an antihistamine eye drop found in the eye care aisle that works in minutes and relieves the itch of allergy eyes for up to 12 hours.

CLARITIN is the No. 1 physician-recommended and pediatrician-recommended non-drowsy over-the-counter allergy brand. The CLARITIN Rx-to-OTC switch in 2002 was the largest switch ever--and the first and only for a non-drowsy antihistamine. For more information on allergies and treatment, visit www.CLARITIN.com.

About Schering-Plough

Schering-Plough Consumer Health Care is the U.S. over-the-counter (OTC) and consumer products business unit of Schering-Plough an innovation-driven, science-centered global health care company. Through its own biopharmaceutical research and collaborations with partners, Schering-Plough creates therapies that help save and improve lives around the world. The company applies its research-and-development platform to human prescription, animal health and consumer health care products. Schering-Plough's vision is to "Earn Trust, Every Day" with the doctors, patients, customers and other stakeholders served by its colleagues around the world. The company is based in Kenilworth, N.J., and its Web site is www.schering-plough.com.

Liqui-Gels is a registered trademark of Catalent Pharma Solutions, Inc.


'/>"/>
SOURCE Schering-Plough Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. FDA Approves Labeling Change for Non-Drowsy CLARITIN(R)
2. New Non-Drowsy CLARITIN(R) Liqui-Gels(R) Now Available
3. Scent To Sleep All Natural Non-Drowsy Sleep Mist Acquired by Innovative Custom Products, Inc. (ICP)
4. Claritin(R) Renews Sponsorship With Allergy Sufferer and NASCAR Star Carl Edwards
5. Photos: New CLARITIN(R) Eye Relieves Itchy Eyes For Up To 12 Hours
6. SCOLR Pharma, Inc. Submits Abbreviated New Drug Application for a 12-hour CDT-based Pseudoephedrine Formulation
7. Pollen, Fruits, Veggies Help Trigger Oral Allergy Syndrome
8. Cell that triggers symptoms in allergy attacks can also limit damage, Stanford researchers find
9. Clean to Ease Allergy and Asthma Symptoms
10. Mount Sinai & ENT and Allergy Associates, LLP affiliate to fight cancer
11. Allergists at Presbyterian Hospital of Dallas Say This Years Fall Allergy Season Could be Worst in Decades
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/9/2016)... ... February 09, 2016 , ... METTLER ... ensure lab personnel have a basic understanding of the techniques they use so ... understanding will help them reduce waste and rework to create a leaner overall ...
(Date:2/9/2016)... Santa Rosa, California (PRWEB) , ... February 09, 2016 , ... ... been rated one of the highest preliminary data vendors in the latest KLAS report, ... 15 years, i2i has led the developing market for population health management (PHM). ...
(Date:2/8/2016)... Bethlehem, PA (PRWEB) , ... February 08, 2016 ... ... announce expanded authorization with BASF Human Nutrition into the Food & Beverage ... BSI has been BASF’s channel partner throughout Canada and USA geographies east ...
(Date:2/8/2016)... ... February 08, 2016 , ... ... packer for pouches, bags, and flow wrapped products at WestPack 2015, February 9-11, ... product manufacturers step up to semi-automatic or fully-automatic case packing with a small ...
(Date:2/8/2016)... Venice, FL (PRWEB) , ... February 08, 2016 ... ... their new community enrichment program serving the greater Venice, FL area, has initiated ... died tragically in a car accident just four days after Christmas. To support ...
Breaking Medicine News(10 mins):
(Date:2/9/2016)...  Misonix, Inc. (NASDAQ: MSON ), an ... markets innovative therapeutic ultrasonic products for spine surgery, ... surgery and other surgical applications, today announced financial ... half of fiscal year 2016 ended December 31, ... --> Highlights for the second quarter and ...
(Date:2/9/2016)... YORK, Pa., Feb. 9, 2016  Unilife Corporation ("Unilife" or "Company") ... of injectable drug delivery systems, today announced its financial results for ... 2015). ... Revenue for the ... million in the same period last year.  Cash receipts from customers ...
(Date:2/9/2016)... Feb. 9, 2016  Jazz Pharmaceuticals plc (Nasdaq: ... 2015 fourth quarter and full year financial results on ... financial markets.  Company management will host a live audio ... p.m. GMT to discuss fourth quarter and full year ... update and guidance for 2016 financial results. ...
Breaking Medicine Technology: